Homozygous SMN2 Deletion is a Major Risk Factor among Twenty-Five Korean Sporadic Amyotrophic Lateral Sclerosis Patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The association between survivor motor neuron (SMN) gene deletion and spinal muscular atrophy suggests that sporadic amyotrophic lateral sclerosis (sALS) may be related to SMN deletion. We examined the association between the SMN genotype and susceptibility to and severity of sALS. Materials and Methods:We genotyped the copy number of SMN1 and SMN2 in 25 patients diagnosed with sporadic ALS and 100 healthy subjects in a Korean population. Onset age and medical research council (MRC) scale were compared among patients according to SMN1 : SMN2 genotypes. Results: There was a significantly higher incidence of homozygous deletion of SMN2 (SMN1 : SMN2 genotype, 2 : 0) in sALS patients (20%) than in the normal controls (2%) (p<0.001). The onset age for patients with homozygous deletion of SMN2 (2 : 0) was significantly younger (34±15.38 years) than that of patients with 2 : 1, 2 : 2 and 2 : 3 of the SMN1 : SMN2 genotype (59.5±5.09; 52.69±16.46 and 50±0.00 years) (p=0.049). The ratio of patients with an MRC scale above G4- was smaller in the 2 : 0 genotype (40%) than in the 2 : 1, 2 : 2 and 2 : 3 genotypes (83.3%, 100% and 100%) (p=0.02). Conclusion: The homozygous SMN2 deletion (2 : 0) was statistically more frequent and associated with earlier onset age and lower MRC scale in Korean sALS patients. These suggest that SMN2 deletion may be one of the factors associated with susceptibility to and severity of sALS in a Korean population.
Abstract
Purpose: The association between survivor motor neuron (SMN) gene deletion and spinal muscular atrophy suggests that sporadic amyotrophic lateral sclerosis (sALS) may be related to SMN deletion. We examined the association between the SMN genotype and susceptibility to and severity of sALS. Materials and Methods:We genotyped the copy number of SMN1 and SMN2 in 25 patients diagnosed with sporadic ALS and 100 healthy subjects in a Korean population. Onset age and medical research council (MRC) scale were compared among patients according to SMN1 : SMN2 genotypes. Results: There was a significantly higher incidence of homozygous deletion of SMN2 (SMN1 : SMN2 genotype, 2 : 0) in sALS patients (20%) than in the normal controls (2%) (p<0.001). The onset age for patients with homozygous deletion of SMN2 (2 : 0) was significantly younger (34±15.38 years) than that of patients with 2 : 1, 2 : 2 and 2 : 3 of the SMN1 : SMN2 genotype (59.5±5.09; 52.69±16.46 and 50±0.00 years) (p=0.049). The ratio of patients with an MRC scale above G4- was smaller in the 2 : 0 genotype (40%) than in the 2 : 1, 2 : 2 and 2 : 3 genotypes (83.3%, 100% and 100%) (p=0.02). Conclusion: The homozygous SMN2 deletion (2 : 0) was statistically more frequent and associated with earlier onset age and lower MRC scale in Korean sALS patients. These suggest that SMN2 deletion may be one of the factors associated with susceptibility to and severity of sALS in a Korean population.
참고문헌 (11)
- Veldink JH, "Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS", Neurology, 56, pp.749~752 (2001)
- Majoor-Krakauer D, "Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson’s disease: evidence of shared genetic susceptibility", Neurology, 44, pp.1872~1877 (1994)
- Schymick JC, "Genetics of sporadic amyotrophic lateral sclerosis", Hum Mol Genet, 16, pp.233~242 (2007)
- Veldink JH, "SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS", Neurology, 65, pp.820~825 (2005)
- Burghes AH, "Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?", Nat Rev Neurosci, 10, pp.597~609 (2009)
- Echaniz-Laguna A, "Homozygous exon 7 deletion of the SMN centromeric gene (SMN2): a potential susceptibility factor for adult-onset lower motor neuron disease", J Neurol, 249, pp.290~293 (2002)
- Brooks BR., "El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases", Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors, 1994, pp.124(Suppl), 96~107
- Kim J, "Association between survivor motor neuron 2 (SMN2) gene homozygous deletion and sporadic lower motor neuron disease in a Korean population", Ann Clin Lab Sci, 40, pp.368~374 (2010)
- Moulard B, "Association between centromeric deletions of the SMN gene and sporadic adult-onset lower motor neuron disease", Ann Neurol, 43, pp.640~644 (1998)
- Corcia P, "SMN1 gene, but not SMN2, is a risk factor for sporadic ALS", Neurology, 67, pp.1147~1150 (2006)
- Zou T, "SMN protects cells against mutant SOD1 toxicity by increasing chaperone activity", Biochem Biophys Res Commun, 364, pp.850~855 (2007)